Quantum BioPharma Statistics

Total Valuation

CSE:QNTM has a market cap or net worth of CAD 43.14 million. The enterprise value is 39.97 million.

Market Cap	43.14M
Enterprise Value	39.97M

Important Dates

The next estimated earnings date is Thursday, May 7, 2026.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

CSE:QNTM has 5.83 million shares outstanding. The number of shares has increased by 189.02% in one year.

Current Share Class	5.83M
Shares Outstanding	5.83M
Shares Change (YoY)	+189.02%
Shares Change (QoQ)	+0.81%
Owned by Insiders (%)	8.01%
Owned by Institutions (%)	8.75%
Float	5.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	6.17
P/TBV Ratio	13.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.11
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.37.

Current Ratio	1.07
Quick Ratio	0.43
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.26

Financial Efficiency

Return on equity (ROE) is -346.87% and return on invested capital (ROIC) is -104.85%.

Return on Equity (ROE)	-346.87%
Return on Assets (ROA)	-67.64%
Return on Invested Capital (ROIC)	-104.85%
Return on Capital Employed (ROCE)	-299.89%
Weighted Average Cost of Capital (WACC)	10.49%
Revenue Per Employee	n/a
Profits Per Employee	-2.11M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.87% in the last 52 weeks. The beta is 0.29, so CSE:QNTM's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-24.87%
50-Day Moving Average	4.83
200-Day Moving Average	15.10
Relative Strength Index (RSI)	67.50
Average Volume (20 Days)	14,127

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-20.98M
Pretax Income	-36.96M
Net Income	-35.89M
EBITDA	-20.23M
EBIT	-20.98M
Earnings Per Share (EPS)	-10.92

Full Income Statement

Balance Sheet

The company has 3.24 million in cash and 2.57 million in debt, giving a net cash position of 669,416 or 0.11 per share.

Cash & Cash Equivalents	3.24M
Total Debt	2.57M
Net Cash	669,416
Net Cash Per Share	0.11
Equity (Book Value)	7.00M
Book Value Per Share	2.44
Working Capital	575,951

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.29M
Capital Expenditures	n/a
Depreciation & Amortization	746,685
Net Borrowing	5.12M
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:QNTM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-189.02%
Shareholder Yield	-189.02%
Earnings Yield	-83.20%
FCF Yield	n/a

Stock Splits

The last stock split was on August 15, 2024. It was a reverse split with a ratio of 0.0153846154.

Last Split Date	Aug 15, 2024
Split Type	Reverse
Split Ratio	0.0153846154

Scores

Altman Z-Score	n/a
Piotroski F-Score	1